Gilgamesh
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
113 University Pl Ste 1019, New York Cit...Phone Number
(347) 967-6831Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Gilgamesh
Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative medicines to transform the treatment of mental health disorders. The companys mission is to shift the traditional approach to psychiatric care away from merely managing symptoms and toward therapies that address the underlying biological drivers of disease. By leveraging deep expertise in neuroscience, medicinal chemistry, and advanced research technologies, Gilgamesh designs and develops new chemical entities that are intended to deliver rapid-acting and long-lasting therapeutic effects while maintaining strong safety and tolerability profiles.Explore more
Gilgamesh Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gilgamesh your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Gilgamesh, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Gilgamesh had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Gilgamesh
Product Launch: Get notified when Gilgamesh launches new products
Website visits: Recent activity has been detected on your website
Check out if Gilgamesh is spiking on competitors!
Funding: Get notified immidiatlly once Gilgamesh has new funding data
Check if Gilgamesh has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Gilgamesh recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Gilgamesh
Find 3 more new buyers
Compare Similar Companies to Gilgamesh
Compare insights from companies similar to Gilgamesh, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gilgamesh is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gilgamesh is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gilgamesh.
Gilgamesh financials insights
Gather financial insights about Gilgamesh, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$27M
2022
Series B
$39M
2026
Private Equity
$6.1M
Series A
$60M
Gilgamesh Tech Stack
A closer look at the technologies used by Gilgamesh
Most Recent Scoops
Funding
Funding
Funding
Funding
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
Engineering, Product Development, Research & Development
Award
Gilgamesh News & Media
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy ...
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD)....AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). Bretisilocin is a novel, short-acting serotonin (5-HT)2A receptor agonist and 5-HT releaser. NORTH...Mental health issues in lockdown drives psychedelic investment - here's the top 5 startups
Psychedelic therapeutics have rapidly gained popularity in the pharma industry in a matter of just a few years. Here are five psychedelic drug discovery startups that have received investment this year.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gilgamesh
Sign Up For FreeTo access detailed company insights
Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative medicines to transform the treatment of mental health disorders. The companys mission is to shift the traditional approach to psychiatric care away from merely managing symptoms and toward therapies that address the underlying biological drivers of... Read More
